India · Delayed Price · Currency is INR | Market Cap | 763.29B +17.9% |
| Revenue (ttm) | 331.82B +7.3% |
| Net Income | 34.87B -0.1% |
| EPS | 60.04 +0.4% |
| Shares Out | n/a |
| PE Ratio | 21.89 |
| Forward PE | n/a |
| Dividend | 4.00 (0.30%) |
| Ex-Dividend Date | Aug 8, 2025 |
| Volume | 48,321 |
| Average Volume | 105,298 |
| Open | 1,330.90 |
| Previous Close | 1,307.70 |
| Day's Range | 1,296.40 - 1,330.90 |
| 52-Week Range | 994.35 - 1,330.90 |
| Beta | n/a |
| RSI | 63.24 |
| Earnings Date | May 30, 2026 |
About Aurobindo Pharma
Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables. The company offers formulation in form of oral solids, liquids, injectables, vaccines, and metered dose inhalers; and APIs, biosimilars, and peptides targeting therapeutic areas, such as central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretrovira... [Read more]
Financial Performance
In fiscal year 2025, Aurobindo Pharma's revenue was 317.24 billion, an increase of 9.39% compared to the previous year's 290.02 billion. Earnings were 34.86 billion, an increase of 9.86%.
Financial StatementsNews
Aurobindo Pharma subsidiary CuraTeQ Biologics enters EU biosimilars agreement with STADA
CuraTeQ Biologics Pvt Ltd, a wholly owned subsidiary of Aurobindo Pharma Ltd, has entered into a marketing and distribution agreement with STADA Arzneimittel AG, a leading European healthcare and phar...
Top stocks to buy today: Stock recommendations for March 25, 2026 - check list
Stock market recommendations: Aurobindo Pharma, Infosys, and Larsen & Toubro (L&T) - these are the stocks that Mehul Kothari, DVP - Technical Research at Anand Rathi Shares and Stock Brokers has recom...
Aurobindo Pharma's subsidiary facility classified as 'Voluntary Action Indicated' by US FDA
Aurobindo Pharma Limited has announced that its wholly owned subsidiary, Apitoria Pharma Private Limited, has received a positive classification from the United States Food and Drug Administration (US...
Pharma sector stocks surge today, March 20: Laurus Labs jumps 2.83%, Natco Pharma up 2.67%, Aurobindo Pharma gains 2.42%
The pharmaceutical sector in India showed positive movement on March 20, 2026, during early trading hours. The S&P BSE HEALTHCARE Index stood at 42,149.5, reflecting a gain of 1.1%. This…
Aurobindo Pharma's Eugia Pharma unit classified as OAI by US FDA
Aurobindo Pharma's subsidiary, Eugia Pharma Specialities Limited, has had its Unit-II classified as 'Official Action Indicated' (OAI) by the United States Food and Drug Administration (US FDA). This f...
Aurobindo Pharma faces ₹77.61 crore GST demand and penalty
Aurobindo Pharma has been ordered to pay a GST demand and penalty totalling ₹77.61 crore by the Principal Commissioner of Customs and Central Tax (Appeals I), Hyderabad. The order confirms…
Aurobindo Pharma's Unit-IV receives VAI classification from US FDA
Aurobindo Pharma's Unit-IV, part of APL Healthcare Limited, has been classified as 'Voluntary Action Indicated' (VAI) by the US FDA, marking the closure of its recent inspection. The inspection of…
Top stocks to buy or sell: Stock market recommendations for today - check list
Stock market recommendations: Aurobindo Pharma Ltd, and Bharat Dynamic are the top buy calls by Somil Mehta, Head of Retail Research, Mirae Asset ShareKhan for March 10, 2026. Persistent is a sell cal...
Aurobindo Pharma subsidiary launches Pomalidomide Capsules in US market, targets $3.3 billion opportunity
Aurobindo Pharma Limited has announced that its wholly owned subsidiary, Eugia Pharma Specialities Limited, has launched Pomalidomide Capsules in strengths of 1 mg, 2 mg, 3 mg and 4 mg…
Top stocks for trade today, March 2: Tata Motors, Hero MotoCorp, Zydus Lifesciences, Aurobindo Pharma, Vedanta and more
Indian stock markets are expected to track a busy news flow on March 2, with developments across pharmaceuticals, infrastructure, auto...
Aurobindo Pharma subsidiary receives 4 observations after US FDA inspection at Telangana facility
Aurobindo Pharma informed the stock exchanges that the United States Food and Drug Administration (US FDA) has completed an inspection...
Pharma sector stocks today, Feb 26: Aurobindo Pharma surge 1.99%, Divis Lab up 1.51%, Zydus Life rises 1.26%
The pharmaceutical sector in India showed positive momentum on February 26, 2026, during early trading hours (around 9:38–9:45 AM IST)....
Aurobindo Pharma faces Rs 169.83 crore GST demand
Aurobindo Pharma has informed stock exchanges that the Goods & Service Tax Department has passed orders demanding recovery of refunds...
Top stocks for trade today, Feb 16: Ola Electric, Aurobindo Pharma, Garden Reach, Torrent Pharma, NBCC and more
A broad set of companies across sectors including infrastructure, pharmaceuticals, renewables, metals, auto components, and FMCG have reported their latest...
Aurobindo Pharma Ltd (BOM:524804) Q3 2026 Earnings Call Highlights: Strong European Growth and ...
Aurobindo Pharma Ltd (BOM:524804) Q3 2026 Earnings Call Highlights: Strong European Growth and Strategic US Expansion
Q3 2026 Aurobindo Pharma Ltd Earnings Call Transcript
Q3 2026 Aurobindo Pharma Ltd Earnings Call Transcript
Top stocks for trade today, Feb 10: Amber Enterprises, Garden Reach, BSE, NTPC Green, Aurobindo Pharma and more
Indian equities are expected to remain stock-specific on February 10 as several companies announced their December-quarter earnings, major order wins,...
Earnings To Watch: Aurobindo Pharma Ltd (NSE:AUROPHARMA) Reports Q3 2026 Result
Earnings To Watch: Aurobindo Pharma Ltd (NSE:AUROPHARMA) Reports Q3 2026 Result
Top Q3 results today, Feb 9: BSE, Zydus Lifesciences, Aurobindo Pharma, Pfizer and more to announce earnings
The December-quarter earnings season gathers pace on February 9, with several listed companies scheduled to announce their Q3 FY26 financial...
Pharma stocks surge: Aurobindo Pharma jumps 5%, Dr Reddy’s and Divi’s Labs rise over 3%
Pharma stocks traded broadly higher in early deals on February 3, tracking strong momentum across the sector. As of 9:32...
Pharma sector stocks today, Feb 1: Shilpa Medicare rally 8%, Sun Pharma up 3%, Aurobindo Pharma falls 2.21%
The Indian pharmaceutical sector showed mixed performance as of February 1, 2026, around 10 AM IST, with many stocks trading...
Pharma sector stocks today, Jan 30: Aurobindo Pharma jumps 3%, Ajanta Pharma up 2%, Natco Pharma rises 2%
The Indian pharma sector stocks showed mixed performance on January 30, 2026, as of approximately 10:31 AM IST. The sector...
Stocks to watch today, Jan 30: Godrej Properties, ACME Solar, Aurobindo Pharma, Voltas, Colgate-Palmolive India and more
Indian equity markets are likely to see stock-specific action on Friday, January 30, as several companies announced key business updates...
Pharma sector stocks fall today: Glenmark Pharma drops 1.38%, Aurobindo Pharma downm 1.25%, Sun Pharma falls 0.87, Dr. Reddy’s Lab down 0.48%
The pharma sector stocks in India experienced declines as of 10 AM on January 20, 2026, aligning with broader market...
Aurobindo Pharma acquires branded non-oncology prescription business of Khandelwal Labs' for Rs 325 crore
India Business News: HYDERABAD: Pharma major Aurobindo Pharma is acquiring the non-oncology prescription business of Mumbai-based Khandelwal Laboratories Pvt Ltd on a goin.